Literature DB >> 33458251

Global proteomic analysis of insulin receptor interactors in glomerular podocytes.

Salman B Hosawi1,2, Jonathan D Humphries1, Richard J Coward3, David Knight4, Martin J Humphries1, Rachel Lennon1,5.   

Abstract

Background: Insulin signalling contributes to diverse cellular activities including protein synthesis, proliferation and cell survival. Insulin resistance describes the inability of cells to activate the insulin signalling pathway effectively; leading to pathological effects in multiple organ systems including the kidney. In diabetic kidney disease, there is progressive glomerular dysfunction and recent studies have demonstrated that the kidney podocyte is a direct target for insulin action. In this study we defined the literature-based insulin receptor (INSR) interactome and utilised an unbiased proteomic approach to examine INSR interactors in podocytes.
Methods: Human podocytes expressing the INSR were characterised under basal and insulin resistant conditions. The INSR was isolated by whole cell immunoprecipitation following a time course stimulation of 2, 7, and 15 minutes with of 100nM insulin. The resulting INSR complexes were analysed by label-free mass spectrometry (MS) to detect protein interactors.
Results: We identified 27 known, direct INSR interactors in addition to novel interactors including doublecortin domain-containing protein 2 (DCDC2). The interaction of DCDC2 with the INSR was confirmed by immunoprecipitation and immunofluorescence, and under insulin resistant conditions, DCDC2 had increased association with the INSR. siRNA knockdown of DCDC2 in podocytes resulted in cell morphological change and altered INSR localisation.
Conclusion: This study provides insight into the complexity of INSR interactors in podocytes and highlights DCDC2 as a novel INSR binding protein. Involvement of this novel interactor in insulin signalling and podocyte biology may explain how insulin resistance alters morphology and integrity of the glomerular filtration barrier. Copyright:
© 2020 Hosawi SB et al.

Entities:  

Keywords:  DCDC2; Podocytes; insulin receptor; insulin resistance; insulin signalling; mass spectrometry-based proteomics

Year:  2020        PMID: 33458251      PMCID: PMC7788524          DOI: 10.12688/wellcomeopenres.16072.1

Source DB:  PubMed          Journal:  Wellcome Open Res        ISSN: 2398-502X


  41 in total

1.  The effects of palmitate on hepatic insulin resistance are mediated by NADPH Oxidase 3-derived reactive oxygen species through JNK and p38MAPK pathways.

Authors:  Dan Gao; Shanwei Nong; Xiuqing Huang; Yonggang Lu; Hongye Zhao; Yajun Lin; Yong Man; Shu Wang; Jiefu Yang; Jian Li
Journal:  J Biol Chem       Date:  2010-07-20       Impact factor: 5.157

Review 2.  Mechanisms of Insulin Action and Insulin Resistance.

Authors:  Max C Petersen; Gerald I Shulman
Journal:  Physiol Rev       Date:  2018-10-01       Impact factor: 37.312

Review 3.  Actin isoforms.

Authors:  I M Herman
Journal:  Curr Opin Cell Biol       Date:  1993-02       Impact factor: 8.382

4.  DCDC2 mutations cause a renal-hepatic ciliopathy by disrupting Wnt signaling.

Authors:  Markus Schueler; Daniela A Braun; Gayathri Chandrasekar; Heon Yung Gee; Timothy D Klasson; Jan Halbritter; Andrea Bieder; Jonathan D Porath; Rannar Airik; Weibin Zhou; Joseph J LoTurco; Alicia Che; Edgar A Otto; Detlef Böckenhauer; Neil J Sebire; Tomas Honzik; Peter C Harris; Sarah J Koon; Meral Gunay-Aygun; Sophie Saunier; Klaus Zerres; Nadina Ortiz Bruechle; Joost P H Drenth; Laurence Pelletier; Isabel Tapia-Páez; Richard P Lifton; Rachel H Giles; Juha Kere; Friedhelm Hildebrandt
Journal:  Am J Hum Genet       Date:  2014-12-31       Impact factor: 11.025

5.  Insulin signaling in type 2 diabetes: experimental and modeling analyses reveal mechanisms of insulin resistance in human adipocytes.

Authors:  Cecilia Brännmark; Elin Nyman; Siri Fagerholm; Linnéa Bergenholm; Eva-Maria Ekstrand; Gunnar Cedersund; Peter Strålfors
Journal:  J Biol Chem       Date:  2013-02-11       Impact factor: 5.157

6.  FGFR1β is a driver isoform of FGFR1 alternative splicing in breast cancer cells.

Authors:  Ming Zhao; Ming-Lei Zhuo; Xiaofeng Zheng; Xiaoping Su; Funda Meric-Bernstam
Journal:  Oncotarget       Date:  2019-01-01

7.  IRS2 and PTEN are key molecules in controlling insulin sensitivity in podocytes.

Authors:  Beatriz Santamaria; Eva Marquez; Abigail Lay; RoseaMarie M Carew; Águeda González-Rodríguez; Gavin I Welsh; Lan Ni; Lorna J Hale; Alberto Ortiz; Moin A Saleem; Derek P Brazil; Richard J Coward; Ángela M Valverde
Journal:  Biochim Biophys Acta       Date:  2015-09-16

8.  The CRAPome: a contaminant repository for affinity purification-mass spectrometry data.

Authors:  Dattatreya Mellacheruvu; Zachary Wright; Amber L Couzens; Jean-Philippe Lambert; Nicole A St-Denis; Tuo Li; Yana V Miteva; Simon Hauri; Mihaela E Sardiu; Teck Yew Low; Vincentius A Halim; Richard D Bagshaw; Nina C Hubner; Abdallah Al-Hakim; Annie Bouchard; Denis Faubert; Damian Fermin; Wade H Dunham; Marilyn Goudreault; Zhen-Yuan Lin; Beatriz Gonzalez Badillo; Tony Pawson; Daniel Durocher; Benoit Coulombe; Ruedi Aebersold; Giulio Superti-Furga; Jacques Colinge; Albert J R Heck; Hyungwon Choi; Matthias Gstaiger; Shabaz Mohammed; Ileana M Cristea; Keiryn L Bennett; Mike P Washburn; Brian Raught; Rob M Ewing; Anne-Claude Gingras; Alexey I Nesvizhskii
Journal:  Nat Methods       Date:  2013-07-07       Impact factor: 28.547

9.  Prolonged exposure of mouse and human podocytes to insulin induces insulin resistance through lysosomal and proteasomal degradation of the insulin receptor.

Authors:  Abigail C Lay; Jenny A Hurcombe; Virginie M S Betin; Fern Barrington; Ruth Rollason; Lan Ni; Lawrence Gillam; Grace M E Pearson; Mette V Østergaard; Hellyeh Hamidi; Rachel Lennon; Gavin I Welsh; Richard J M Coward
Journal:  Diabetologia       Date:  2017-08-29       Impact factor: 10.122

10.  Global, regional, and national burden of chronic kidney disease, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017.

Authors: 
Journal:  Lancet       Date:  2020-02-13       Impact factor: 79.321

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.